• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

Message on the passing of Marleen Boelaert from DNDi Executive Director Dr Bernard Pécoul

16 Jun 2020
  • English
    • English
    • Français

It is with profound sadness that we learned of the passing of Marleen Boelaert. Throughout her life, she was a champion of the fight against neglected tropical diseases, always showing great professionalism as well as unmatched and unfailing commitment to helping the most neglected, even though for the past few years she was fighting her own battle against disease.

Passionate about her research and transmission to future generations, she trained countless young researchers, especially in Africa, Asia, and Latin America, at the Institute of Tropical Medicine in Antwerp (IMT), which offered public health masters and PhDs to researchers or scientists from countries affected by tropical diseases.

Prof Marleen Boelaert in kala azar endemic villages in Bihar in 2006.
Prof Marleen Boelaert in kala azar endemic villages in Bihar in 2006. The visit, conducted with the entomology team from RMRI (Dr Diwakar Dinesh and Dr Vijay Kumar) was part of KALANET project, a cluster randomized trial to assess the effectiveness of long lasting insecticidal nets for prevention of kala azar in India and Nepal.

Marleen co-founded the HAT Platform in 2005, and since then she remained highly committed to the control of sleeping sickness, encouraging many members of the platform to further their training. The HAT Platform Coordinator, Florent Mbo, based in the Democratic Republic of the Congo, recalls: “It is thanks to her that we were able to train and afterwards manage in the best possible way the HAT control programmes. She always supported HAT research, created numerous partnerships between IMT and the national programmes. She was passionate about her work, but also attentive to her students. She guided us and encouraged us to surpass ourselves and find our own solutions.”

Our paths first crossed in the early ‘80s when she was a member of the medical department and later the President of Médecins Sans Frontières (Doctors without Borders) Belgium. In those days already, through her work with MSF, she was involved in activities promoting awareness on neglected diseases and the creation of an environment favourable and necessary for the creation of DNDi. Since then, Marleen remained close to DNDi, as a member of the Scientific Advisory Committee representing MSF, as an active participant in our projects on Chagas disease in Latin America, or as an advisor for our sleeping sickness and leishmaniasis projects.

“It was a blessing for me that I got the opportunity to work with Marleen. I learnt so much from her, she was first a mentor to me and then became a faithful friend,” says Dr Suman Rijal, Director of DNDi South Asia in New Delhi. Their collaboration started over 20 years ago at the B.P. Koirala Institute of Health Sciences (BPKIHS) in Nepal where they built over time, with partners, a reference research centre that played a crucial role in the leishmaniasis elimination strategies in Nepal. Marleen was very active in the field, and had a very clear vision on how to create effective multicultural partnerships.

We will all remember Marleen’s sharp and vivid intelligence, her enthusiasm, her kindness, her courage, her humility. She was a great listener, always ready to help solve difficulties, and she had the knack to make people agree even if there were some differences, always with a view to further the cause.

All members of DNDi who were lucky enough to meet her shall miss her greatly.

Our thoughts go to her family and friends.

Photo credit: Albert Picado

Read, watch, share

Loading...
Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

Marco Krieger
News
30 Apr 2025

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

Screening activities in village in Guinea
News
25 Apr 2025

Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi

Two man outside of a hospital talking with a nurse
Press releases
24 Apr 2025

Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease

Woman walking in a laboratory
Press releases
23 Apr 2025

DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease

Stories
16 Apr 2025

Drug discovery explained: Chagas – How to prove treatments work?

Statements
16 Apr 2025

Statement from the Drugs for Neglected Diseases initiative (DNDi) on the conclusion of WHO Pandemic Agreement negotiations

Press releases
15 Apr 2025

New treatment for cryptococcal meningitis enters Phase II trial as global HIV funding cuts threaten to cause a massive increase in advanced HIV disease

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License